Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of Shengdi Dahuang Decoction
in the treatment of acute hemorrhagic stroke by the randomized, controlled, double-blind,
multi-center trial design project.